113 related articles for article (PubMed ID: 3732346)
1. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture.
Mussoni L; Conforti G; Gambacorti-Passerini C; Alessio G; Pepe S; Vaghi M; Erba E; Amato G; Landoni F; Mangioni C
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):373-80. PubMed ID: 3732346
[TBL] [Abstract][Full Text] [Related]
2. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function.
Colucci M; Semeraro N; Montemurro P; Chiumarulo P; Triggiani R; Morrone LF; Schena FP
Kidney Int; 1991 Jun; 39(6):1213-7. PubMed ID: 1910125
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.
Zacharski LR; Memoli VA; Ornstein DL; Rousseau SM; Kisiel W; Kudryk BJ
J Natl Cancer Inst; 1993 Aug; 85(15):1225-30. PubMed ID: 8331683
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
5. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
Camiolo SM; Greco WR
Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro.
Karlan BY; Amin W; Band V; Zurawski VR; Littlefield BA
Gynecol Oncol; 1988 Sep; 31(1):103-12. PubMed ID: 3410341
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid.
Huber K; Wojta J; Kirchheimer JC; Ermler D; Binder BR
Eur J Clin Invest; 1988 Dec; 18(6):595-9. PubMed ID: 2852112
[TBL] [Abstract][Full Text] [Related]
9. Fibrin activatable urokinase (FA-UK): a latent form of UK found in urine related to a complex with an inhibitor/fibrin-interacting cofactor.
Dwivedi C; Pannell R; Gurewich V
Thromb Res; 1988 Jul; 51(2):197-208. PubMed ID: 3055414
[TBL] [Abstract][Full Text] [Related]
10. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
Dong Q; Zhou MH; Subbarao V; Ts'ao CH
Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
[TBL] [Abstract][Full Text] [Related]
11. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
12. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
Krishnamurti C; Alving B
Rev Infect Dis; 1989; 11 Suppl 4():S843-6. PubMed ID: 2501855
[TBL] [Abstract][Full Text] [Related]
13. A simple spectrophotometric assay of plasminogen activator: comparison with the fibrinolytic method.
Zaoui D; Le Fèvre B; Magdelenat H; Bieth JG
Clin Chim Acta; 1984 Aug; 141(2-3):101-9. PubMed ID: 6541536
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.
Casslén B; Bossmar T; Lecander I; Astedt B
Eur J Cancer; 1994; 30A(9):1302-9. PubMed ID: 7999418
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity of normal human blood monocytes.
Grau E; Moroz LA
Thromb Res; 1989 Jan; 53(2):145-62. PubMed ID: 2922705
[TBL] [Abstract][Full Text] [Related]
16. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer.
Ho CH; Yuan CC; Liu SM
Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296
[TBL] [Abstract][Full Text] [Related]
19. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
Ny T; Bjersing L; Hsueh AJ; Loskutoff DJ
Endocrinology; 1985 Apr; 116(4):1666-8. PubMed ID: 3918858
[TBL] [Abstract][Full Text] [Related]
20. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
Idell S; James KK; Levin EG; Schwartz BS; Manchanda N; Maunder RJ; Martin TR; McLarty J; Fair DS
J Clin Invest; 1989 Aug; 84(2):695-705. PubMed ID: 2788176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
